Transcripts

Regeneron Pharmaceuticals (REGN) earnings call transcripts

Earnings call transcripts for Regeneron Pharmaceuticals, with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter as evidence of broad commercial momentum and a diversified pipeline, while emphasizing disciplined investment and upcoming catalysts.

    Jul 30, 2026Confident0.72